SPC471
dolutegravir or a pharmaceutically acceptable salt, including dolutegravir sodium, and lamivudine
Status:
UmsóknApplication date:
3.6.2024Application published:
15.7.2024
Max expiry date:
2.7.2034Medicine name:
DOVATOMedicine for children:
No
Timeline
Today
3.6.2024Application
15.7.2024Publication
2.7.2034Expires
Marketing license
IS authorization number:
EU/1/19/1370Date:
19.7.2019
Foreign authorization number:
EU/1/19/1370Date:
1.7.2019
Owner
Name:
VIIV Healthcare CompanyAddress:
251 Little Falls Drive, Wilmington, DE 19808 US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP3494972